.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AA02_QuingestanolAndEthinyles.QuingestanolAndEthinyles .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AA02_QuingestanolAndEthinyles.QuingestanolAndEthinyles| name: | QuingestanolAndEthinylestradiol | |
| ATC code: | G03AA02 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 0.5 | mg |
| volume of distribution: | 4 | L |
| clearance: | 14 | L/h |
| other parameters in model implementation | ||
Quingestanol and ethinylestradiol is a combination oral contraceptive containing a synthetic progestin (quingestanol) and a synthetic estrogen (ethinylestradiol). It was historically used for female hormonal contraception but is no longer widely approved or marketed in most countries.
No peer-reviewed pharmacokinetic (PK) publication was found reporting specific PK model parameters for the combination product of quingestanol and ethinylestradiol; estimates are derived from general PK knowledge of similar oral contraceptives in healthy adult women.